Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication
Reto Kurmann(Carol Davila University of Medicine and Pharmacy), Ashima Makol(Mayo Clinic), Yasser Radwan(Mayo Clinic), Eric L. Matteson(Mayo Clinic in Arizona), Cynthia S. Crowson(Mayo Clinic in Florida), Edward El‐Am(Mayo Clinic in Arizona), Avneek Singh Sandhu(Mayo Clinic in Arizona), Rekha Mankad(Mayo Clinic in Arizona)
Cited by 22
Related Papers
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis Care & Research|2015|1.1k